1 June 2025 - The June 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.

The June issue of the Schedule includes just a few new/revised listings of note: 

• Semaglutide (Ozempic) - new strength
• Tiotropium bromide monohydrate (Spiriva Respimat) - new formulation
• Tiotropium bromide monohydrate with olodaterol hydrochloride (Spiolto Respimat) - new formulation

Read summary of PBS changes